FMP
BME
80.9 EUR
0.25 (0.309%)
Mr. Juan Lopez-Belmonte Encina
Healthcare
Biotechnology
https://www.rovi.es
BME
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin; Neparvis to treat symptomatic chronic heart failure with reduced ejection in adult patients; Absorcol, Vytorin, and Orvatez to diet in patients with hypercholesterolemia; Hirobriz Breezhaler and Ulunar Breezhaler that are long-acting bronchodilators...
N/A
ES0157261019
N/A
Calle José Isbert, 2
34 91 021 30 00
ES
1,925
Dec 5, 2007
-
BME
Biotechnology
Healthcare
-
ES0157261019
ES
80.9
0.47
80.18k
4.32B
-
37.96-81.5
62.66
-
-
-
-
25.28
-
https://www.rovi.es
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.